Pharma Cold Chain Logistics Best Practices 2025 Memandu
Diperbarui November 26 2025
Pharma cold chain logistics best practices protect lifesaving medicines and vaccines from temperature fluctuations that can ruin their potency. Di dalam 2025 the global cold chain logistics market is booming—forecast to surge from about KITA $324.85 miliar masuk 2024 ke KITA $862.33 miliar oleh 2032—because biologics, advanced therapies and obesity treatments depend on controlled temperatures. Namun hingga 20 % of temperaturesensitive drugs are compromised in transit and nearly 50 % vaksin are wasted due to poor cold chain management. If you handle pharmaceuticals, you need a robust cold chain strategy that ensures products remain within their required ranges (often 2–8 °C), complies with regulations like GDP/GMP and the Undang-Undang Keamanan Rantai Pasokan Narkoba (DSCSA), and leverages emerging technologies such as IoT sensors, AI analytics and blockchain for realtime visibility. This guide answers your questions and provides pharma cold chain logistics best practices to help you safeguard medicines, reduce waste and stay compliant in 2025.

Why are pharma cold chain logistics best practices essential? – We explain the stakes for patient safety and financial integrity, and why 2–8 °C matters for most vaccines and biologics.
Which regulations govern pharma cold chain logistics in 2025? – Learn about GDP, GMP, DSCSA and regional frameworks and what they mean for your operations.
What technologies are transforming cold chain logistics? – Explore IoT sensors, Pengoptimalan rute AI, blockchain, solarpowered storage and automation.
How do you choose packaging and equipment? – Compare insulated containers, pengirim palet, bahan perubahan fase, cryogenic shippers and smart packaging.
How can you build a compliant and resilient cold chain? – Follow our best practice checklist for manufacturing, penyimpanan, transportasi dan distribusi.
What trends and market developments will shape 2025? – Understand the growth of biologics, sustainability pressures and the push for endtoend visibility【542920472744014†L621-L699】.
What are common cold chain questions? – Find practical answers to FAQs about temperature ranges, excursions, kepatuhan dan teknologi.
Why are Pharma Cold Chain Logistics Best Practices Essential?
Temperature control protects product potency and patient safety. Vaccines and biologic therapies lose effectiveness when exposed to unsuitable temperatures; Misalnya, traditional vaccines must stay between 2 °C dan 8 ° C., some biologics require –20 °C storage and gene or cell therapies demand –80 °C hingga –150 °C cryogenic conditions. Brief excursions can render medicines ineffective. Studies estimate up to 20 % of temperaturesensitive drugs are compromised during transit, costing billions and risking patient health. With the pharmaceutical cold chain market expected to reach KITA $6.6 miliar masuk 2025 Dan KITA $9.6 miliar oleh 2035, ensuring reliable cold chain logistics is a competitive necessity.
Financial and reputational stakes are high. Vaccine spoilage wastes almost 50 % of doses worldwide, and cold chain failures can trigger recalls, regulatory penalties and reputational damage. Maintaining a dependable cold chain preserves product integrity, supports compliance and protects your brand.
Persyaratan suhu bervariasi menurut produk. Understanding specific ranges helps you choose appropriate equipment and packaging. The table below summarises common categories:
Temperature Categories and Benefits
| Kategori Produk | Kisaran Suhu Khas | Mengapa itu penting | Manfaat praktis |
| Vaksin standar | 2–8 ° C. (36–46 ° F.) | Kebanyakan vaksin (flu, hepatitis, HPV) remain potent only within this refrigerated range | Ensures immunity and avoids costly revaccination |
| Biologi & peptides | 2–8 ° C.; some require –20 °C | Antibodi monoklonal, insulin and GLP1 agonists degrade quickly outside controlled refrigeration | Maintains drug efficacy and reduces patient risks |
| Gene & terapi sel | –80 °C hingga –150 °C (kriogenik) | CART therapies and viral vectors require ultracold storage; temperatures can reach –190 °C | Preserves living cells and maximises therapeutic success |
| Suhu ruangan terkontrol (CRT) obat | 15–25 °C (59–77 °F) | Many oral drugs and some biologics can be stored at CRT but need monitoring to avoid heat or freeze damage | Avoids product degradation and reduces energy costs |
| Obesity medications | 2–8 ° C. | GLP1 receptor agonists like Wegovy and Mounjaro require refrigeration | Supports growing patient demand and reduces waste |
Practical Tips and RealWorld Insights
Always confirm manufacturer ranges. Never assume one range fits all products; verify each drug’s specification.
Gunakan peralatan kelas medis. Purposebuilt refrigerators and freezers deliver uniform temperature; avoid dormitorystyle units that may freeze vaccines.
Minimalkan bukaan pintu. Frequent door openings introduce warm air and cause fluctuations.
Label storage areas. Clear labels such as “2–8 °C medicines” reduce handling errors.
Record everything. Document every temperature measurement; accurate records support audits and help identify deviations.
Contoh dunia nyata: Selama peluncuran COVID 19, clinics using calibrated freezers with IoT sensors maintained ultracold temperatures for mRNA vaccines. Continuous alerts enabled staff to correct deviations quickly, reducing spoilage and ensuring uninterrupted immunisation.
Which Regulations Govern Pharma Cold Chain Logistics in 2025?
Pharmaceutical cold chain logistics operates within a complex regulatory landscape. Failing to comply with guidelines can result in fines, shipment quarantines or license suspensions. Here are the major frameworks you must understand:
Good Distribution and Manufacturing Practice (PDB/GMP)
GDP and GMP guidelines—issued by bodies like the European Medicines Agency (Ema), KITA. Administrasi Makanan dan Obat -obatan (FDA) and World Health Organization (SIAPA)—set standards for temperature control, ketertelusuran dan pelatihan. Key principles include validated equipment, continuous monitoring and risk management.
Undang-Undang Keamanan Rantai Pasokan Narkoba (DSCSA)
Di Amerika Serikat, itu DSCSA requires a fully electronic, interoperable tracking system by Agustus 27 2025. Wholesale distributors must exchange transaction information, verify product identifiers at the package level and report suspect medicines. Dispensers must also electronically trace products, with deadlines extending to November 2026 for small dispensers.
Other Regional Frameworks
EU GDP/GMP: Mencaplok 11 mandates validated electronic systems and secure data handling.
USP <1079>: Provides guidelines for shipping temperaturesensitive products.
IATA/WHO: Set standards for transporting vaccines and dry ice.
NIST & UKAS Calibration: Ensures measurement accuracy of monitoring devices.
EU Clinical Trials Regulation (UE 536/2014): Governs investigational products during trials.
Regulatory Table
| Peraturan | Cakupan & Persyaratan Utama | Implikasinya bagi Anda |
| DSCSA (KITA) | Electronic traceability, serialised product identifiers, full data exchange by Aug 27 2025 | Requires interoperable systems and robust data management; noncompliance can halt shipments |
| EU GDP/GMP | Validated electronic systems, secure data handling, audit trails | Mandates calibrated equipment, electronic records and user access controls |
| USP <1079> | Guidelines for shipping temperaturesensitive products | Supports best practices for packaging, pemantauan dan dokumentasi |
| IATA/WHO | Standards for transporting vaccines and dry ice | Ensures safe air transport and global consistency |
| NIST/UKAS | Calibration of devices to recognised standards | Ensures measurement accuracy for temperature monitoring |
Kiat Kepatuhan
Review upcoming DSCSA deadlines and assess whether your systems meet interoperability requirements.
Map your operations to identify which regional guidelines apply; mengadaptasi proses yang sesuai.
Create a compliance checklist covering calibration, pemantauan, dokumentasi dan pelatihan.
Partner with validated vendors. Work with suppliers who provide documentation for audits.
Upgrade electronic systems to maintain secure data, audit trails and user access controls.
Contoh dunia nyata: A.S. wholesale distributor modernised its warehouse management system to meet DSCSA requirements. By August 2025 it had integrated serialisation, digital documentation and secure user access, avoiding shipment delays and penalties.
Emerging Technologies Transforming Pharma Cold Chain Logistics
Digital tools and hardware are reshaping cold chain logistics in 2025, enhancing visibility, control and efficiency.
IoTEnabled Sensors and RealTime Monitoring
Internet of Things devices—such as smart tapes, sensors and GPS trackers—collect data on temperature, kelembaban dan lokasi secara real time. When sensors detect unsafe conditions, they send alerts via text or email, Mengaktifkan tindakan korektif langsung. IoT sensors with GPS provide endtoend visibility, and predictive analytics can reduce unplanned equipment downtime by up to 50 % and repair costs by 10–20 %.
Kecerdasan Buatan (Ai) dan Analisis Prediktif
AI algorithms analyse historical and realtime data to optimise shipping routes, memperkirakan permintaan dan memprediksi kegagalan peralatan. AIpowered route optimisation considers traffic and weather conditions, reducing transit time and quality degradation. Studies indicate AI improves decisionmaking and reduces costs across the cold chain.
Blockchain for EndtoEnd Traceability
Blockchain creates a tamperproof ledger linking every transaction chronologically. In the pharmaceutical cold chain it ensures data integrity, prevents manipulation and enhances compliance. Realtime temperature logs, shipment times and custody data can be shared securely among stakeholders. This transparency builds trust and simplifies audits.
SolarPowered and Sustainable Cold Storage
Unreliable power grids and rising energy costs have spurred solarpowered cold storage units. Solar installations reduce total energy costs—utility rates average 13.10 sen per kWh while commercial solar can cost 3.2–15,5 sen per kWh. Sustainable packaging such as recyclable containers and biodegradable wraps also reduces environmental impact.
Otomasi dan Robotika
Fasilitas penyimpanan dingin mengadopsi sistem penyimpanan dan pengambilan otomatis (AS/RS) and robotic handling to address labour shortages and improve efficiency. Robots minimise human error and operate without breaks, increasing throughput. Sekitar 80 % gudang tetap tidak terotomatisasi, meninggalkan ruang untuk pertumbuhan.
Portable Cryogenic Freezers and Modular UltraCold Storage
Advanced therapies require ultracold temperatures. Portable cryogenic freezers maintain –80 °C hingga –150 °C conditions and provide realtime tracking and warning notifications. Modular units allow facilities to scale capacity quickly and accommodate multiple temperature zones.
Innovation Summary Table
| Teknologi | Manfaat utama | Apa artinya bagimu |
| Sensor IoT & GPS | Realtime temperature/location data; peringatan otomatis | Prevents excursions, optimises routes and enhances visibility |
| Ai & analitik prediktif | Permintaan perkiraan, identifies optimal paths | Reduces transit time and preserves product quality |
| Blockchain | Tamperproof records, secure data sharing | Simplifies audits and strengthens compliance |
| Penyimpanan bertenaga surya | Lower energy costs, remote operation | Enables sustainable cold chain in offgrid areas |
| Automation/robotics | Continuous operation, lebih sedikit kesalahan | Improves warehouse efficiency and labour utilisation |
| Freezer kriogenik portabel | Ultracold mobility | Supports gene and cell therapies in diverse locations |
Implementation Tips
Install IoT sensors on every shipment to monitor temperature and location.
Use AIenabled route planning to adjust deliveries based on realtime traffic and weather.
Adopt blockchain logs for highvalue or highly regulated products.
Evaluate solar options if your facility faces unreliable power or high energy costs.
Plan for automation to cope with labour shortages and ensure consistency.
Contoh dunia nyata: A Southeast Asian logistics provider deployed blockchain and IoT sensors to monitor vaccine shipments. By sharing realtime temperature and humidity logs with all stakeholders, the system eliminated data manipulation and improved regulatory compliance.
Selecting Packaging and Equipment for Pharma Cold Chain Logistics
Effective cold chain management requires more than refrigerators. Packaging and equipment must preserve product integrity during manufacturing, penyimpanan dan transportasi. Wadah terisolasi, pengirim palet, phasechange materials and cryogenic units each offer unique benefits.
Opsi Pengemasan
Insulated containers and liners: Represent about 40 % dari pasar pengemasan rantai dingin. They maintain temperature stability for 96 hours or more and can be reusable.
Pallet shippers: Designed for largevolume shipments, they account for roughly 25 % of the market and can integrate smart sensors.
Bahan perubahan fasa (PCMS) and gel packs: Provide precise temperature control by absorbing or releasing latent heat; custom PCMs exist for frozen (–20 °C), didinginkan (+5 ° C.) dan lingkungan (+22 ° C.) conditions【542920472744014†L511-L448】.
Panel isolasi vakum (VIP): Offer superior insulation and thermal stability and can be custom shaped.
Cryogenic shippers and LN2 vapour shippers: Menjaga –80 °C to –190 °C for gene and cell therapies.
Smart packaging platforms: Combine AI and IoT to recommend packaging and track temperature in real time.
Reusable vs SingleUse Packaging
Reusable systems reduce total cost of ownership and environmental impact; the market for reusable temperaturecontrolled packaging reached KITA $2.5 miliar masuk 2024 and is expected to double by 2033. Singleuse options may be necessary for regulatory reasons or when return logistics are impractical. Saat memilih kemasan, consider route duration, seasonal temperatures and sustainability goals.
Equipment Considerations
Medicalgrade refrigerators/freezers: Provide uniform temperature and microprocessor controls with alarms.
Ultralow freezers: Required for biologics and gene therapies; ensure redundancy and backup power.
IoTenabled shippers and data loggers: Offer continuous temperature and location data; kalibrasi secara teratur.
Backup generators and redundant power: Ensure temperature stability during outages.
Packaging Selection Table
| Larutan | Temperature Range Supported | Use Cases | Keuntungan |
| Wadah terisolasi (EPP, VIP) | 2–8 ° C., –20 °C, –80 °C (with appropriate refrigerants) | Pengiriman vaksin, Biologi, insulin | Ringan, dapat digunakan kembali, ukuran khusus; maintain temperature for 96 jam atau lebih |
| Pallet shippers | 2–8 ° C., –20 °C, cryogenic with dry ice | Largevolume distribution, international transport | Long hold times; tahan lama; can integrate smart sensors |
| PCM & Paket gel | Rentang tertentu (–20 °C, +5 ° C., +22 ° C.) | Pengiriman campuran, uji klinis | Kontrol suhu yang tepat; dapat digunakan kembali; safe for dry ice restrictions |
| Cryogenic freezers & LN2 vapour shippers | –80 °C to –190 °C | Cell and gene therapy, tissue engineering | Maintain viability of living cells; require specialised handling |
| Kemasan cerdas | All ranges; dynamic | Highvalue biologics, pengiriman jarak jauh | Data integration, route optimisation; reduces packaging errors |
UserLevel Tips
Conduct thermal validation of packaging for specific routes and conditions.
Refrigeran pra-kondisi (Paket gel, PCMS) to the correct temperature before packing.
Avoid midroute repacking; each opening introduces risk.
Use data loggers and GPS trackers to document temperature throughout transit.
Pertimbangkan sistem yang dapat digunakan kembali for regular routes to reduce costs and waste.
Contoh dunia nyata: A biotech firm shipping a gene therapy used cryogenic LN₂ vapour shippers with IoT sensors. These containers maintained –150 °C untuk lebih 120 jam and provided realtime data, enabling proactive interventions and avoiding product loss.
Building a Compliant and Resilient Pharma Cold Chain System
A robust cold chain extends beyond equipment; it relies on processes, people and risk management. The table below summarises core components across the pharmaceutical cold chain.
Core Components Across the Cold Chain
| Panggung | Kegiatan Utama | Kisaran Suhu Khas | Implikasi Praktis |
| Manufacturing | Maintain specified temperatures for raw materials and finished products; document them for tech transfer | 2–8 °C for most biologics; –20 °C or lower for gene therapies | Ensures ingredients remain stable and prevents degradation before packaging |
| Penyimpanan | Use refrigerators, cold rooms and warehouses with continuous monitoring and alarms | 2–8 ° C. (didinginkan) or lower for ultracold products | Protects inventory; temperature logs support audits and recalls |
| Angkutan | Employ refrigerated vehicles and insulated packaging; data loggers track conditions in transit | Usually 2–8 °C; dry ice or liquid nitrogen for cryogenic transport | Minimises risk during delivery; documents chain of custody |
| Distribusi | Wholesalers and pharmacies use controlled facilities until dispensing | Same as storage | Ensures final product quality and prevents waste |
Best Practice Checklist
Validasi peralatan: Confirm refrigerators, freezers and data loggers meet GMP/GDP standards and calibrate them regularly.
Menerapkan pemantauan berkelanjutan: Use IoT devices and alarm systems to track temperature and humidity in real time.
Maintain robust documentation: Rekam data suhu, calibration certificates and handling procedures; consider blockchain for tamperproof records.
Melatih personel: Provide comprehensive training on GDP requirements, equipment operation and emergency response.
Kembangkan rencana darurat: Prepare backup power sources, alternative routes and protocols for transferring products to secondary storage.
Melakukan penilaian risiko: Identify potential failures (pemadaman listrik, vehicle breakdowns, extreme weather) and mitigate them with redundancy and predictive tools.
Audit secara teratur: Include internal and external audits to verify compliance and uncover gaps.
Interactive SelfAssessment Tool
Engage your team by adding a Kuis Kesiapan Rantai Dingin. Ask questions like:
Do you know the correct storage temperature for each product?
Are your refrigerators and freezers calibrated within the last year?
Do you use realtime monitoring with alerts?
Do you have documented SOPs for packing and handling?
Is there a contingency plan for power failures or transit delays?
A scoring system can highlight weak areas and direct users to resources or services for improvement. Misalnya, a regional pharmacy chain implemented a quarterly selfassessment and achieved a 30 % pengurangan perjalanan suhu dalam waktu enam bulan.
2025 Developments and Trends in Pharma Cold Chain Logistics
The pharmaceutical cold chain is evolving rapidly due to new therapies, rising consumer expectations and sustainability mandates.
Ikhtisar Tren
Otomasi dan robotika: Cold storage facilities deploy robots to address labour shortages and improve consistency.
Keberlanjutan: Pendinginan hemat energi, renewable energy and recyclable packaging are becoming industry standards. Sustainable practices help reduce carbon footprints—cold chain infrastructure accounts for around 2 % emisi CO₂ global.
Visibilitas ujung ke ujung: Advanced tracking systems provide realtime location and temperature data. The hardware segment led the cold chain tracking and monitoring market in 2022, holding over 76.4 % dari pangsa pasar.
Infrastructure modernisation: Upgrades in insulation, refrigeration systems and onsite renewable power are essential to meet efficiency and compliance demands.
AI dan analisis prediktif: AI mengoptimalkan rute, memperkirakan permintaan dan memprediksi kegagalan peralatan; demand forecasting addresses uncertainty in supply chains.
Growth in pharma cold chain: The rising demand for temperaturesensitive pharmaceuticals and biologics is a key driver. Sekitar 20 % of new drugs in development are gene and cellbased therapies requiring cold chain logistics. The global pharmaceutical cold chain market is expected to reach KITA $1,454 miliar oleh 2029, dengan CAGR sebesar 4.71 % dari 2024 ke 2029.
Sustainability and green supply chains: Sustainability tops the list at major industry events, with ecofriendly materials and renewable energy emphasised. Cold chain operators invest in energyefficient refrigeration and ecofriendly refrigerants.
Endtoend visibility as standard: Full visibility is now required across product recalls, kepatuhan, cold chain integrity and raw material sourcing.
Resilience and risk management: PostCOVID19, supply networks focus on resilience and nearshoring to reduce disruptions. Simulation tools and scenario planning help prepare for unpredictable events.
Ikhtisar Kemajuan Terkini
Rise of biologics and advanced therapies: Lebih 40 % of newly approved drugs in 2024 were biologics, driving demand for refrigerated and cryogenic storage.
Refrigerated storage growth: Demand for 2–8 °C storage is growing faster than other segments; biologics are projected to grow 6 % CAGR melalui 2035 dan vaksin 5 % CAGR. Obesity medications are expected to triple in volume by 2030.
Cold storage market expansion: The global cold storage market (food and pharmaceuticals) diperkirakan akan tumbuh KITA $35.7 miliar masuk 2025 ke KITA $72 miliar oleh 2033.
Modernisation of warehouses: Tentang 80 % gudang tetap tidak terotomatisasi, offering significant potential for robotics and automation.
High growth for cold chain logistics: The global cold chain logistics market is predicted to grow from KITA $324.85 miliar masuk 2024 ke KITA $862.33 miliar oleh 2032 due to demand for biologics and stricter regulations.
Standardisation and integration: Oleh 2025, 74 % of logistics data diharapkan terstandarisasi, memungkinkan integrasi yang lebih baik di seluruh rantai pasokan.
Wawasan Pasar dan Pandangan Masa Depan
Therapies are becoming more sophisticated, making temperaturecontrolled logistics a strategic asset. Biologics and personalised medicines are highly sensitive to temperature and frequently require refrigerated storage. Vaccines and rare disease treatments also rely on the 2–8 °C range. Obesity treatments using GLP1 agonists are fuelling explosive growth in refrigerated volumes. Sementara itu, environmental and ESG pressures push companies to adopt energyefficient refrigeration, renewable power and biodegradable packaging. Strategic partnerships and data standardisation enable better integration across supply chains, improving resilience.
Pertanyaan yang sering diajukan
Q1: What does pharmaceutical cold chain logistics mean?
It refers to controlling temperature during manufacturing, penyimpanan, transport and distribution of temperaturesensitive medicines. The goal is to keep products like vaccines, biologics and gene therapies within specific ranges (MISALNYA., 2–8 ° C.) to maintain potency and safety.
Q2: How are temperature ranges categorised in the cold chain?
The Healthcare Distribution Alliance classifies four ranges: didinginkan (2–8 ° C.) for insulin and many vaccines; beku (–20 °C hingga –40 °C) for DNA and mRNA vaccines; ultralow (–45 °C to –93 °C) for certain vaccines; dan kriogenik (–150 °C to –190 °C) for cell and gene therapies. Knowing these categories helps you select suitable equipment and packaging.
Q3: What happens if temperature excursions occur?
Temperature excursions—when products fall outside recommended ranges—are the leading cause of product loss. Hingga 80 % of pharmaceutical losses are attributed to temperature excursions. Excursions degrade drug potency, trigger costly recalls and compromise patient safety. Implement continuous monitoring and contingency plans to mitigate risks.
Q4: How can pharmacies ensure compliance with GDP guidelines?
Pharmacies should use validated equipment, continuous monitoring with realtime alerts, robust documentation and regular staff training. They must maintain products within 2–8 °C or other specified ranges, conduct risk assessments and develop contingency plans for power outages or transit delays.
Q5: What new technologies are emerging in 2025 untuk logistik rantai dingin?
Key innovations include IoT sensors for realtime monitoring, Pengoptimalan rute yang digerakkan oleh AI, blockchain for tamperproof recordkeeping, penyimpanan dingin bertenaga surya, automation and robotics. Portable cryogenic units and modular ultracold storage support gene and cell therapies.
Q6: Why is sustainability important in pharmaceutical cold chains?
Cold storage facilities consume large amounts of energy and contribute to carbon emissions. Sustainable practices—such as using renewable energy, energyefficient refrigeration and recyclable packaging—reduce environmental impact and help companies meet regulatory and consumer expectations. Solarpowered units can also lower operational costs.
Q7: How will the pharmaceutical cold chain evolve over the next decade?
The next ten years will see rapid growth in 2–8 °C storage, automation and realtime visibility. Biologics are projected to grow 6 % CAGR melalui 2035; vaksin 5 %, and obesity medications will triple by 2030. Ultracold logistics will expand to support cell and gene therapies, while sustainable and modular solutions will become standard.
Ringkasan dan Rekomendasi
Kunci takeaways:
Keep temperatures correct. Understand the specific range for each product and use validated, calibrated equipment to maintain it. Most vaccines and biologics require 2–8 °C, while gene and cell therapies need –80 °C to –150 °C.
Ikuti peraturan. Adhere to GDP/GMP guidelines, prepare for DSCSA electronic traceability by Aug 27 2025, and comply with regional standards.
Rangkullah teknologi. Sensor IoT, AI analytics and blockchain improve visibility, optimise routes and ensure tamperproof records.
Pilih kemasan yang sesuai. Gunakan wadah berinsulasi, pengirim palet, PCMs or cryogenic units based on temperature requirements and route duration.
Train and plan. Educate staff on cold chain protocols, maintain detailed documentation and develop contingency plans for emergencies.
Prioritaskan keberlanjutan. Invest in energyefficient refrigeration, renewable power and recyclable packaging.
Action Recommendations:
Assess your cold chain readiness. Conduct a selfassessment to identify gaps in equipment, pemantauan, dokumentasi dan pelatihan. Score results to prioritise improvements.
Upgrade monitoring infrastructure. Implement IoT sensors and AIenabled analytics to achieve realtime visibility and predictive insights.
Create a DSCSA compliance roadmap. Plan for electronic traceability, serialisation and secure user access by August 27 2025.
Optimise packaging and transport. Choose reusable insulated containers or cryogenic shippers as needed; validate thermal performance for your routes.
Berinvestasi dalam keberlanjutan. Jelajahi penyimpanan bertenaga surya, energyefficient refrigeration and recyclable packaging to reduce costs and environmental impact.
Berkolaborasi dengan para ahli. Partner with 3PL/4PL providers and packaging specialists who understand pharmaceutical regulations and offer endtoend visibility.
Tentang tempk
Pada Tempk, we specialise in cold chain packaging and temperature control solutions for pharmaceuticals. With an inhouse R&D centre and stringent quality control, we design and manufacture insulated boxes, Paket gel, pallet covers and reusable packaging tailored for 0–10 °C, sub10 °C and ultracold ranges. Our validated systems help clients comply with GDP/GMP requirements while reducing waste and supporting sustainability goals. We prioritise ecofriendly materials and innovative designs to keep your shipments safe and efficient in 2025.
Panggilan untuk bertindak: Ready to strengthen your pharma cold chain? Contact Tempk for customised solutions and expert guidance on building a resilient, sustainable cold chain system.